Grayson, P
Moreover, SGLT2is have been shown to reduce the incidence of cardiovascular and kidney disease in people with and without diabetes [5, 6], suggesting that these medications should be considered for prevention of cardiovascular and kidney disease, irrespective of HbA 1c levels
Youre not alone, and support is available Retatrutide isnt currently available to support weight loss, but if you have a BMI over 35, you may be eligible for Ovivas NHS-accredited and funded weight loss programme
Get enough high-quality sleep
Participants taking GLP-1RAs semaglutide or tirzepatide in a retrospective survey study, reported reduced drinking and binge drinking episodes 18
Zeng W, Li H, Chen Y, Lv H, Liu L, Ran J et al